Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has launched its rare blood disorder franchise. Sanofi acquired Bioverativ and Ablynx, which ...
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has launched its rare blood disorder franchise. Sanofi acquired Bioverativ and Ablynx, which ...
No comments:
Post a Comment